Report Detail

Pharma & Healthcare Global (United States, European Union and China) Weight Loss Drugs Market Research Report 2019-2025

  • RnM3352336
  • |
  • 24 April, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global (United States, European Union and China) Weight Loss Drugs Market Research Report 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Weight Loss Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Liauid
      • 1.3.3 Tablets
    • 1.4 Market Segment by Application
      • 1.4.1 Global Weight Loss Drugs Market Share by Application (2019-2025)
      • 1.4.2 Weight-reducing Aid
      • 1.4.3 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Weight Loss Drugs Market Size
      • 2.1.1 Global Weight Loss Drugs Revenue 2014-2025
      • 2.1.2 Global Weight Loss Drugs Sales 2014-2025
    • 2.2 Weight Loss Drugs Growth Rate by Regions
      • 2.2.1 Global Weight Loss Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Weight Loss Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Weight Loss Drugs Sales by Manufacturers
      • 3.1.1 Weight Loss Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Weight Loss Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Weight Loss Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Weight Loss Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Weight Loss Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Weight Loss Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Weight Loss Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Weight Loss Drugs Market
    • 3.6 Key Manufacturers Weight Loss Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Liauid Sales and Revenue (2014-2019)
      • 4.1.2 Tablets Sales and Revenue (2014-2019)
    • 4.2 Global Weight Loss Drugs Sales Market Share by Type
    • 4.3 Global Weight Loss Drugs Revenue Market Share by Type
    • 4.4 Weight Loss Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Weight Loss Drugs Sales by Application

    6 United States

    • 6.1 United States Weight Loss Drugs Breakdown Data by Company
    • 6.2 United States Weight Loss Drugs Breakdown Data by Type
    • 6.3 United States Weight Loss Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Weight Loss Drugs Breakdown Data by Company
    • 7.2 European Union Weight Loss Drugs Breakdown Data by Type
    • 7.3 European Union Weight Loss Drugs Breakdown Data by Application

    8 China

    • 8.1 China Weight Loss Drugs Breakdown Data by Company
    • 8.2 China Weight Loss Drugs Breakdown Data by Type
    • 8.3 China Weight Loss Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Weight Loss Drugs Breakdown Data by Company
    • 9.2 Rest of World Weight Loss Drugs Breakdown Data by Type
    • 9.3 Rest of World Weight Loss Drugs Breakdown Data by Application
    • 9.4 Rest of World Weight Loss Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Weight Loss Drugs Sales by Countries
      • 9.4.2 Rest of World Weight Loss Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Roche
      • 10.1.1 Roche Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.1.4 Weight Loss Drugs Product Introduction
      • 10.1.5 Roche Recent Development
    • 10.2 GSK group
      • 10.2.1 GSK group Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.2.4 Weight Loss Drugs Product Introduction
      • 10.2.5 GSK group Recent Development
    • 10.3 Teva
      • 10.3.1 Teva Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.3.4 Weight Loss Drugs Product Introduction
      • 10.3.5 Teva Recent Development
    • 10.4 Sandoz(Novartis)
      • 10.4.1 Sandoz(Novartis) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.4.4 Weight Loss Drugs Product Introduction
      • 10.4.5 Sandoz(Novartis) Recent Development
    • 10.5 STADA-VN J.V.Co., Ltd
      • 10.5.1 STADA-VN J.V.Co., Ltd Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.5.4 Weight Loss Drugs Product Introduction
      • 10.5.5 STADA-VN J.V.Co., Ltd Recent Development
    • 10.6 Hexal AG
      • 10.6.1 Hexal AG Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.6.4 Weight Loss Drugs Product Introduction
      • 10.6.5 Hexal AG Recent Development
    • 10.7 National Company For Pharmaceutical Industry
      • 10.7.1 National Company For Pharmaceutical Industry Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.7.4 Weight Loss Drugs Product Introduction
      • 10.7.5 National Company For Pharmaceutical Industry Recent Development
    • 10.8 Lunan Pharmaceutical Group Corporation
      • 10.8.1 Lunan Pharmaceutical Group Corporation Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.8.4 Weight Loss Drugs Product Introduction
      • 10.8.5 Lunan Pharmaceutical Group Corporation Recent Development
    • 10.9 Zein Pharmaceutical
      • 10.9.1 Zein Pharmaceutical Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.9.4 Weight Loss Drugs Product Introduction
      • 10.9.5 Zein Pharmaceutical Recent Development
    • 10.10 Hisun
      • 10.10.1 Hisun Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Weight Loss Drugs
      • 10.10.4 Weight Loss Drugs Product Introduction
      • 10.10.5 Hisun Recent Development
    • 10.11 Taj Pharmaceuticals Ltd
    • 10.12 Kabir Life Sciences & Research
    • 10.13 Dm Pharma
    • 10.14 China Zhongshan Pharm

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Weight Loss Drugs Sales Channels
      • 11.2.2 Weight Loss Drugs Distributors
    • 11.3 Weight Loss Drugs Customers

    12 Market Forecast

    • 12.1 Global Weight Loss Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Weight Loss Drugs Sales Forecast by Type
    • 12.3 Global Weight Loss Drugs Sales Forecast by Application
    • 12.4 Weight Loss Drugs Forecast by Regions
      • 12.4.1 Global Weight Loss Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Weight Loss Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Weight Loss Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Weight Loss Drugs.

      This report studies the global market size of Weight Loss Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Weight Loss Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Roche
      GSK group
      Teva
      Sandoz(Novartis)
      STADA-VN J.V.Co., Ltd
      Hexal AG
      National Company For Pharmaceutical Industry
      Lunan Pharmaceutical Group Corporation
      Zein Pharmaceutical
      Hisun
      Taj Pharmaceuticals Ltd
      Kabir Life Sciences & Research
      Dm Pharma
      China Zhongshan Pharm

      Market Segment by Product Type
      Liauid
      Tablets

      Market Segment by Application
      Weight-reducing Aid
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Weight Loss Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Weight Loss Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Weight Loss Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Weight Loss Drugs . Industry analysis & Market Report on Weight Loss Drugs is a syndicated market report, published as Global (United States, European Union and China) Weight Loss Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Weight Loss Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,624.96
      3,937.44
      5,249.92
      2,972.78
      4,459.17
      5,945.56
      353,856.24
      530,784.36
      707,712.48
      233,154.86
      349,732.30
      466,309.73
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report